These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5911844)

  • 41. Mode of action of antidepressant drugs.
    Sulser F
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):14-20. PubMed ID: 6406444
    [No Abstract]   [Full Text] [Related]  

  • 42. The involvement of serotonin and noradrenaline in the psychopathological processes of stress and depression: animal models and the effect of antidepressant drugs.
    Płaźnik A; Kostowski W
    Pol J Pharmacol Pharm; 1991; 43(4):301-22. PubMed ID: 1811222
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the mechanism of the sedative effect of lithium carbonate].
    Komissarova RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(6):917-21. PubMed ID: 6000192
    [No Abstract]   [Full Text] [Related]  

  • 44. [Central mechanisms of vomiting: the effect of histamine, 5-hydroxytryptamine, noradrenaline, nicotine and morphine].
    Beleslin D; Samardzić R; Krstić S; Mićić D; Strbac M
    Glas Srp Akad Nauka Med; 1985; (37):169-84. PubMed ID: 3842678
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of 5-hydroxytryptamine and iproniazid on pregnancy.
    POULSON E; BOTROS M; ROBSON JM
    Science; 1960 Apr; 131(3407):1101-2. PubMed ID: 14434518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of neurotropic drugs on glucose metabolism in rat brain in vivo.
    Bachelard HS; Lindsay JR
    Biochem Pharmacol; 1966 Aug; 15(8):1053-8. PubMed ID: 5973155
    [No Abstract]   [Full Text] [Related]  

  • 47. Enhancement of amphetamine action after interruption of ascending serotonergic pathways.
    Green TK; Harvey JA
    J Pharmacol Exp Ther; 1974 Jul; 190(1):109-17. PubMed ID: 4136228
    [No Abstract]   [Full Text] [Related]  

  • 48. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion.
    Archer T; Minor BG; Post C
    Brain Res; 1985 Apr; 333(1):55-61. PubMed ID: 3158373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 50. Noradrenaline-serotonin interactions in the control of sexual behavior in the male rat: DSP4-induced noradrenaline depletion antagonizes the facilitatory effect of serotonin receptor agonists, 5-MeODMT and lisuride.
    Fernandez-Guasti A; Hansen S; Archer T; Jonsson G
    Brain Res; 1986 Jul; 377(1):112-8. PubMed ID: 3730848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of noradrenaline, 5-hydroxytryptamine and acetylcholine injected intraventricularly on the rat's behaviour.
    Herman ZS
    Acta Physiol Pol; 1973; 24(1):87-91. PubMed ID: 4740404
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of drugs on vibration tolerance.
    Aston R; Roberts VL
    Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):289-99. PubMed ID: 5841186
    [No Abstract]   [Full Text] [Related]  

  • 53. Monoaminergic mechanisms of stimulation-produced analgesia.
    Akil H; Liebeskind JC
    Brain Res; 1975 Aug; 94(2):279-96. PubMed ID: 125141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relations for the inhibition of 5-hydroxytryptamine uptake by tricyclic antidepressants into synaptosomes from serotoninergic neurones in rat brain homogenates.
    Horn AS; Trace RC
    Br J Pharmacol; 1974 Jul; 51(3):399-403. PubMed ID: 4451753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple substrate determination of monoamine oxidase distribution and iproniazid inhibition in rat brain.
    La Motte RH; Schmidt DE; Ruliffson WS
    J Neurochem; 1969 May; 16(5):725-30. PubMed ID: 5770018
    [No Abstract]   [Full Text] [Related]  

  • 57. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
    Boullin DJ; Glenton PA
    Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depression of pulmonary 5-hydroxytryptamine uptake by metabolic inhibitors.
    Steinberg H; Bassett DJ; Fisher AB
    Am J Physiol; 1975 May; 228(5):1298-303. PubMed ID: 1130533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diminution of 5-hydroxytryptamine in thrombocytes in vitro by chlorpromazine and related compounds.
    BARTHOLINI G; PLETSCHER A; GEY KF
    Experientia; 1961 Dec; 17():541-2. PubMed ID: 13865426
    [No Abstract]   [Full Text] [Related]  

  • 60. [Electrophysiological changes after head irradiation of rabbits receiving aminazin].
    Delitsyna NS
    Radiobiologiia; 1965; 5(2):231-6. PubMed ID: 5871960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.